GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (STU:CUP) » Definitions » Equity-to-Asset

Chugai Pharmaceutical Co (STU:CUP) Equity-to-Asset : 0.85 (As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Chugai Pharmaceutical Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Chugai Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was €10,309 Mil. Chugai Pharmaceutical Co's Total Assets for the quarter that ended in Jun. 2024 was €12,124 Mil. Therefore, Chugai Pharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Jun. 2024 was 0.85.

The historical rank and industry rank for Chugai Pharmaceutical Co's Equity-to-Asset or its related term are showing as below:

STU:CUP' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.76   Med: 0.82   Max: 0.87
Current: 0.85

During the past 13 years, the highest Equity to Asset Ratio of Chugai Pharmaceutical Co was 0.87. The lowest was 0.76. And the median was 0.82.

STU:CUP's Equity-to-Asset is ranked better than
87.25% of 1043 companies
in the Drug Manufacturers industry
Industry Median: 0.6 vs STU:CUP: 0.85

Chugai Pharmaceutical Co Equity-to-Asset Historical Data

The historical data trend for Chugai Pharmaceutical Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co Equity-to-Asset Chart

Chugai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.81 0.79 0.77 0.76 0.84

Chugai Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.84 0.84 0.87 0.85 -

Competitive Comparison of Chugai Pharmaceutical Co's Equity-to-Asset

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chugai Pharmaceutical Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Equity-to-Asset falls into.



Chugai Pharmaceutical Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Chugai Pharmaceutical Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=10353.114/12308.148
=0.84

Chugai Pharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

Equity to Asset (Q: Jun. 2024 )=Total Stockholders Equity/Total Assets
=10308.634/12123.98
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chugai Pharmaceutical Co  (STU:CUP) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Chugai Pharmaceutical Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Chugai Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and covid-19 patients.

Chugai Pharmaceutical Co Headlines

No Headlines